FDA cleared apps
Los Altos, California-based Gauss Surgical has raised $3.
Australia-based Analytica has received FDA 510(k) clearance for PeriCoach, its smartphone-connected device that helps women monitor their pelvic floor exercises.
By Bradley Merrill Thompson
With the growth of health apps, entrepreneurs often need to determine if FDA regulates their particular mobile app.
Israel-based Voyant Health, a subsidiary of Germany-based medical technology company Brainlab, received FDA clearance for its iPad app, called TraumaCad Mobile, which helps orthopedic surgeons with their pre-operative surgical planning.
Vital Art and Science, developers of myVisionTrack, a vision test service for patients with age-related macular degeneration or diabetic eye disease, has received a second FDA clearance for their platform, which includes an app and a provider dashboard.
Los Altos, California-based Gauss Surgical has received an FDA 510(k) clearance for its Triton iPad app, which can now estimate the surgical blood loss in canisters that hold blood.
Bradley Merrill Thompson
At the end of last week the FDA posted two draft guidance documents related to digital health.
Bethesda, Maryland-based cellular-enabled blood glucose meter company Telcare has raised $32.
Last week the FDA granted 510(k) clearance to a mobile-based cognitive test called DANA (Defense Automated Neurobehavioral Assessment), which helps healthcare providers better assess the medical or psychological state of their patients.
MobiHealthNews has been tracking FDA clearances for smartphone-connected medical devices and standalone apps for many years.